|Bid||0.00 x 3000|
|Ask||0.00 x 800|
|Day's range||118.78 - 121.65|
|52-week range||96.00 - 222.00|
|Beta (5Y monthly)||1.20|
|PE ratio (TTM)||9.12|
|Earnings date||21 Feb 2023 - 27 Feb 2023|
|Forward dividend & yield||6.56 (5.46%)|
|Ex-dividend date||19 Sept 2022|
|1y target est||106.00|
Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today announced that it was named to FORTUNE Magazine's 2022 list of the 100 Fastest-Growing Companies. This recognition marks the company's fourth straight year of inclusion on the prestigious list, with Medifast being one of only 24 companies returning to the list from 2021 and one of only 11 companies that made the list for three or more consecutive years.
Medifast ( NYSE:MED ) Third Quarter 2022 Results Key Financial Results Revenue: US$390.4m (down 5.6% from 3Q 2021). Net...
International Flavors' (IFF) Q3 top line beats estimates but came in line with last year. The company lowered the 2022 sales guidance citing foreign currency impact and a challenging operating environment.